Login / Signup

Long-term Outcomes after the Discontinuation of Anti-Tumor Necrosis Factor-α Therapy in Patients with Inflammatory Bowel Disease under Clinical Remission: A Korean Association for the Study of Intestinal Disease Multicenter Study.

Sung Noh HongEun Ae KangSoo-Kyung ParkSung Noh HongYou Sun KimKi Bae BangKyeong Ok KimHong Sub LeeSang Bum KangSeung Yong ShinEun Mi SongJong-Pil ImChang Hwan Choinull null
Published in: Gut and liver (2021)
More than 60% of IBD patients in remission under anti-TNF therapy relapsed within 5 years of treatment cessation. Anti-TNF re-induction was effective. However, half of the patients discontinued anti-TNF therapy, and 50% of these patients discontinued treatment owing to loss of response.
Keyphrases